Cargando…

Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India

CONTEXT: There has been a rise in the incidence of type 1 diabetes mellitus (T1DM) in India. The prevalence of thyroid autoantibodies and thyroid dysfunction is common in T1DM. AIMS: The aim of this study is to determine the incidence of thyroid dysfunction and thyroid autoantibodies in T1DM subject...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanyal, Debmalya, Majumder, Anirban, Chaudhuri, Soumyabrata Roy, Chatterjee, Sudip
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Medknow Publications & Media Pvt Ltd 2017
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240080/
https://www.ncbi.nlm.nih.gov/pubmed/28217497
http://dx.doi.org/10.4103/2230-8210.195998
_version_ 1782496001402077184
author Sanyal, Debmalya
Majumder, Anirban
Chaudhuri, Soumyabrata Roy
Chatterjee, Sudip
author_facet Sanyal, Debmalya
Majumder, Anirban
Chaudhuri, Soumyabrata Roy
Chatterjee, Sudip
author_sort Sanyal, Debmalya
collection PubMed
description CONTEXT: There has been a rise in the incidence of type 1 diabetes mellitus (T1DM) in India. The prevalence of thyroid autoantibodies and thyroid dysfunction is common in T1DM. AIMS: The aim of this study is to determine the incidence of thyroid dysfunction and thyroid autoantibodies in T1DM subjects, without any history of thyroid disease, and the prevalence of glutamic acid decarboxylase (GAD) antibody, Islet antigen-2 antibody (IA2), thyroid peroxidase (TPO), and thyroglobulin autoantibodies (Tg-AB) in T1DM subjects. SETTINGS AND DESIGN: This was a cross-sectional clinical-based study. SUBJECTS AND METHODS: Fifty subjects (29 males, 31 females) with T1DM and without any history of thyroid dysfunction were included in the study. All subjects were tested for GAD antibody, IA2 antibody, TPO antibody, thyroglobulin antibody, free thyroxine, and thyroid-stimulating hormone. STATISTICAL ANALYSIS USED: A Chi-square/pooled Chi-square test was used to assess the trends in the prevalence of hypothyroidism. A two-tailed P < 0.05 was considered statistically significant. RESULTS: The mean age of the subjects was 23.50 years. 9.8% of subjects were below the age of 12 years, 27.45% of subjects were of age 12–18 years, 37.25% of subjects were of age 19–30 years, and 25.49% of subjects were above 30 years. 78% were positive autoantibody for GAD, 30% for IA-2, 24% for TPO, and 16% were positive for Tg-AB. A total of 6.0% of T1DM subjects had evidence of clinical hypothyroidism, but the prevalence of subclinical hyperthyroidism (SCH) varied from 32% to 68.0% for we considered different definitions of SCH as advocated by different guidelines. All subjects with overt hypothyroidism had positive GAD and thyroid autoantibodies. One (2%) subject had clinical hyperthyroidism with strongly positive GAD, TPO, and Tg-AB. CONCLUSIONS: We found a high prevalence of GAD, IA2, TPO, and Tg-AB in our T1DM subjects. A substantial proportion of our subjects had undiagnosed thyroid dysfunction with a preponderance of subclinical hypothyroidism. All T1DM subjects with overt hypothyroidism or hyperthyroidism had positive GAD and thyroid autoantibodies. The high prevalence of undiagnosed thyroid dysfunction highlights the importance of regular thyroid screening in T1DM subjects.
format Online
Article
Text
id pubmed-5240080
institution National Center for Biotechnology Information
language English
publishDate 2017
publisher Medknow Publications & Media Pvt Ltd
record_format MEDLINE/PubMed
spelling pubmed-52400802017-02-17 Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India Sanyal, Debmalya Majumder, Anirban Chaudhuri, Soumyabrata Roy Chatterjee, Sudip Indian J Endocrinol Metab Original Article CONTEXT: There has been a rise in the incidence of type 1 diabetes mellitus (T1DM) in India. The prevalence of thyroid autoantibodies and thyroid dysfunction is common in T1DM. AIMS: The aim of this study is to determine the incidence of thyroid dysfunction and thyroid autoantibodies in T1DM subjects, without any history of thyroid disease, and the prevalence of glutamic acid decarboxylase (GAD) antibody, Islet antigen-2 antibody (IA2), thyroid peroxidase (TPO), and thyroglobulin autoantibodies (Tg-AB) in T1DM subjects. SETTINGS AND DESIGN: This was a cross-sectional clinical-based study. SUBJECTS AND METHODS: Fifty subjects (29 males, 31 females) with T1DM and without any history of thyroid dysfunction were included in the study. All subjects were tested for GAD antibody, IA2 antibody, TPO antibody, thyroglobulin antibody, free thyroxine, and thyroid-stimulating hormone. STATISTICAL ANALYSIS USED: A Chi-square/pooled Chi-square test was used to assess the trends in the prevalence of hypothyroidism. A two-tailed P < 0.05 was considered statistically significant. RESULTS: The mean age of the subjects was 23.50 years. 9.8% of subjects were below the age of 12 years, 27.45% of subjects were of age 12–18 years, 37.25% of subjects were of age 19–30 years, and 25.49% of subjects were above 30 years. 78% were positive autoantibody for GAD, 30% for IA-2, 24% for TPO, and 16% were positive for Tg-AB. A total of 6.0% of T1DM subjects had evidence of clinical hypothyroidism, but the prevalence of subclinical hyperthyroidism (SCH) varied from 32% to 68.0% for we considered different definitions of SCH as advocated by different guidelines. All subjects with overt hypothyroidism had positive GAD and thyroid autoantibodies. One (2%) subject had clinical hyperthyroidism with strongly positive GAD, TPO, and Tg-AB. CONCLUSIONS: We found a high prevalence of GAD, IA2, TPO, and Tg-AB in our T1DM subjects. A substantial proportion of our subjects had undiagnosed thyroid dysfunction with a preponderance of subclinical hypothyroidism. All T1DM subjects with overt hypothyroidism or hyperthyroidism had positive GAD and thyroid autoantibodies. The high prevalence of undiagnosed thyroid dysfunction highlights the importance of regular thyroid screening in T1DM subjects. Medknow Publications & Media Pvt Ltd 2017 /pmc/articles/PMC5240080/ /pubmed/28217497 http://dx.doi.org/10.4103/2230-8210.195998 Text en Copyright: © Indian Journal of Endocrinology and Metabolism http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work non-commercially, as long as the author is credited and the new creations are licensed under the identical terms.
spellingShingle Original Article
Sanyal, Debmalya
Majumder, Anirban
Chaudhuri, Soumyabrata Roy
Chatterjee, Sudip
Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
title Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
title_full Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
title_fullStr Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
title_full_unstemmed Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
title_short Thyroid profile and autoantibodies in Type 1 diabetes subjects: A perspective from Eastern India
title_sort thyroid profile and autoantibodies in type 1 diabetes subjects: a perspective from eastern india
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5240080/
https://www.ncbi.nlm.nih.gov/pubmed/28217497
http://dx.doi.org/10.4103/2230-8210.195998
work_keys_str_mv AT sanyaldebmalya thyroidprofileandautoantibodiesintype1diabetessubjectsaperspectivefromeasternindia
AT majumderanirban thyroidprofileandautoantibodiesintype1diabetessubjectsaperspectivefromeasternindia
AT chaudhurisoumyabrataroy thyroidprofileandautoantibodiesintype1diabetessubjectsaperspectivefromeasternindia
AT chatterjeesudip thyroidprofileandautoantibodiesintype1diabetessubjectsaperspectivefromeasternindia